FIELD: chemistry.
SUBSTANCE: invention relates to salts consisting of succinic acid and maleic acid and a compound represented by the formula (I)
. Invention also relates to crystals thereof and a pharmaceutical composition based thereon.
EFFECT: obtaining novel compounds that can be used in medicine to treat cancer.
15 cl, 3 tbl, 15 dwg, 6 ex
Title | Year | Author | Number |
---|---|---|---|
THERAPEUTIC AGENT FOR TREATING BREAST CANCER | 2016 |
|
RU2730503C2 |
PYRIDON DERIVATIVES | 2013 |
|
RU2632885C2 |
BENZIMIDAZOLE DERIVATIVES AS ROR-GAMMA MODULATORS | 2017 |
|
RU2760366C2 |
MONOCYCLIC PYRIDINE DERIVATIVE | 2014 |
|
RU2645352C2 |
CRYSTAL (6S,9AS)-N-BENZYL-8-({6-[3-(4-ETHYLPIPERAZIN-1-YL)AZETIDIN-1-YL]PYRIDIN-2-YL}METHYL)-6-(2-FLUORINE-4-HYDROXYBENZYL)-4,7-DIOXO-2-(PROP-2-EN-1-YL)HEXAHYDRO-2H-PYRAZINO[2,1-C][1,2,4]TRIAZINE-1(6H)-CARBOXAMIDE | 2016 |
|
RU2723551C2 |
INDAZOLE DERIVATIVE SALTS AND THEIR CRYSTALS | 2017 |
|
RU2747399C2 |
PYRIDINES SUBSTITUTED WITH HETEROARYL AND APPLICATION METHODS | 2017 |
|
RU2756743C2 |
PYRIDONE DERIVATIVE HAVING TETRAHYDROPYRANYLMETHYL GROUP | 2015 |
|
RU2707953C2 |
NITROGEN-CONTAINING AROMATIC DERIVATIVES, PHARMACEUTICAL COMPOSITION CONTAINING THEREOF, METHOD FOR TREATMENT AND USING | 2003 |
|
RU2310651C2 |
CRYSTALLINE FORMS OF DIAZABICLOCTANE DERIVATIVE AND A METHOD OF THEIR PRODUCTION | 2014 |
|
RU2801220C2 |
Authors
Dates
2018-06-25—Published
2015-08-17—Filed